Detalhe da pesquisa
1.
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Crit Care
; 26(1): 304, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192801